Ó£»¨ÊÓÆµ

Skip to main content

Table 3 Age adjusted prevalence of pre-diabetes and diabetes by residence, wealth status and region, STEPS survey

From: Prevalence and factors associated with pre-diabetes and diabetes mellitus in Kenya: results from a national survey

Indicator

Diabetes

(% [95%CI])

Pre-diabetes

(% [95%CI])

Diabetes awareness

(% [95%CI])

Diabetes treatment (% [95%CI])

Diabetes control (% [95%CI])

National

2.4 [01.8:03.0]

03.1 [02.2:04.0]

43.7 [29.1:59.5]

21.3 [12.0:35.1]

07.0 [03.6:13.2]

Residence

ÌýÌýÌýÌýÌý

 R³Ü°ù²¹±ô

1.9 [01.3:02.5]

02.7 [01.8:03.7]

39.5 [25.2:55.7]

14.9 [08.6:24.6]

07.7 [03.3:17.1]

 U°ù²ú²¹²Ô

3.4 [02.1:04.7]

03.5 [01.6:05.3]

48.6 [22.4:75.6]

28.7 [11.1:56.4]

06.2 [02.2:16.2]

Wealth status

ÌýÌýÌýÌýÌý

 1 - Poorest

1.6 [00.7:02.5]

03.3 [01.1:05.5]

17.8 [04.0:52.9]

00.0 [00.0:00.0]

00.0 [00.0:00.0]

 2

1.5 [00.7:02.2]

02.3 [01.1:03.4]

53.0 [27.1:77.3]

23.1 [08.7:48.7]

13.2 [03.8:37.1]

 3

2.0 [01.1:02.9]

03.0 [01.4:04.6]

32.5 [16.2:54.5]

28.4 [13.3:50.7]

17.6 [06.8:38.5]

 4

3.0 [01.8:04.3]

01.6 [00.7:02.6]

49.5 [23.7:75.5]

33.2 [10.3:68.2]

02.5 [00.6:09.8]

 5 - Richest

5.2 [02.5:07.9]

04.9 [01.4:08.4]

52.9 [16.5:86.5]

16.0 [04.5:43.4]

04.5 [00.9:19.2]

Sex

ÌýÌýÌýÌýÌý

 F±ð³¾²¹±ô±ð

2.8 [02.0:03.6]

03.3 [02.2:04.4]

44.9 [28.6:62.4]

33.7 [19.8:51.3]

10.5 [05.4:19.6]

 M²¹±ô±ð

2.0 [01.1:02.9]

02.8 [01.6:04.1]

42.0 [21.8:65.2]

03.5 [01.1:10.6]

01.9 [00.3:09.7]

Age (years)

ÌýÌýÌýÌýÌý

 18–29

0.6 [00.3;01.4]

02.1 [01.1;03.8]

27.8 [05.8:70.6]

08.2 [01.6:32.8]

05.3 [00.6:32.7]

 30–44

2.3 [01.5;03.5]

02.9 [02.0;04.2]

21.7 [09.2:43.0]

16.1 [06.7:34.1]

09.0 [02.9:24.5]

 45–59

7.1 [04.8;10.3]

05.3 [03.5;07.8]

54.9 [32.0:75.9]

28.5 [12.2:53.2]

06.0 [02.2:15.3]

 60–69

6.0 [03.7;09.5]

06.4 [03.9;10.2]

70.1 [45.7:86.8]

20.1 [08.0:42.2]

07.5 [02.4:21.2]

Total (N)

4069

3934

135

135

135

  1. NB: Awareness, treatment and control estimates are not age adjusted. Awareness was defined as prior diagnosis of diabetes by a healthcare professional among diabetic participants. Treatment was defined as receiving pharmacologic treatment to lower blood glucose in the previous 2 weeks among diabetic participants. Control was defined as having a fasting blood glucose of < 7Ìýmmol/l while on pharmacologic treatment among diabetic participants